Literature DB >> 17056809

Chronic administration of UMP ameliorates the impairment of hippocampal-dependent memory in impoverished rats.

Lisa A Teather1, Richard J Wurtman.   

Abstract

We have previously shown that chronic, but not acute, dietary supplementation with CDP-choline prevents the hippocampal-dependent memory deficits manifested by aged rats and by rats reared under impoverished environmental conditions. In rats, dietary CDP-choline is rapidly metabolized into cytidine and choline; the cytidine is then readily converted to uridine, which enters the brain and, via conversion to UTP and CTP, increases brain levels of membrane phosphatides. Hence, we have assessed whether administering a uridine source (UMP) instead of CDP-choline can also ameliorate the memory deficits in rats reared under impoverished environmental conditions. At weaning, 32 male Sprague-Dawley rats were exposed to either enriched (EC) or impoverished (IC) conditions for 3 mo. Concurrently, IC and EC rats were given access to either a control diet or a diet supplemented with 0.1% UMP. Rats were then assessed for learning and memory skills using 2 versions of the Morris water maze, the hidden platform version that assesses hippocampal-dependent cognitive memory processing, and the visible platform version that assesses striatal-dependent habit memory. As expected, exposure to the impoverished environment impaired hippocampal-dependent, but not striatal-dependent learning and memory. Supplementation with UMP prevented this cognitive dysfunction, as had been observed with supplemental CDP-choline. These results suggest that IC rats do not use and/or remember their spatial strategies for task solving as well as EC rats, and that long-term dietary supplementation with UMP alleviates this dysfunction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056809     DOI: 10.1093/jn/136.11.2834

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  13 in total

Review 1.  Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses.

Authors:  Richard J Wurtman; Mehmet Cansev; Toshimasa Sakamoto; Ismael Ulus
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

Review 2.  Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides.

Authors:  R J Wurtman; M Cansev; I H Ulus
Journal:  J Nutr Health Aging       Date:  2009-03       Impact factor: 4.075

Review 3.  Synapse formation and cognitive brain development: effect of docosahexaenoic acid and other dietary constituents.

Authors:  Richard J Wurtman
Journal:  Metabolism       Date:  2008-10       Impact factor: 8.694

4.  5'-CMP and 5'-UMP promote myogenic differentiation and mitochondrial biogenesis by activating myogenin and PGC-1α in a mouse myoblast C2C12 cell line.

Authors:  Kosuke Nakagawara; Chieri Takeuchi; Kazuya Ishige
Journal:  Biochem Biophys Rep       Date:  2022-07-15

Review 5.  Translational research in nicotine dependence.

Authors:  Jill R Turner; Allison Gold; Robert Schnoll; Julie A Blendy
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

6.  Chronic administration of DHA and UMP improves the impaired memory of environmentally impoverished rats.

Authors:  Sarah Holguin; Yi Huang; Jenny Liu; Richard Wurtman
Journal:  Behav Brain Res       Date:  2008-03-18       Impact factor: 3.332

7.  Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils.

Authors:  Sarah Holguin; Joseph Martinez; Camille Chow; Richard Wurtman
Journal:  FASEB J       Date:  2008-07-07       Impact factor: 5.191

Review 8.  Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses.

Authors:  Mehmet Cansev; Richard J Wurtman; Toshimasa Sakamoto; Ismail H Ulus
Journal:  Alzheimers Dement       Date:  2007-12-21       Impact factor: 21.566

9.  Synaptogenesis: Modulation by Availability of Membrane Phospholipid Precursors.

Authors:  Mehmet Cansev
Journal:  Neuromolecular Med       Date:  2016-06-01       Impact factor: 3.843

10.  Souvenaid®: a new approach to management of early Alzheimer's disease.

Authors:  C W Ritchie; J Bajwa; G Coleman; K Hope; R W Jones; M Lawton; M Marven; P Passmore
Journal:  J Nutr Health Aging       Date:  2014-03       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.